VAIM Signs Exclusive U.S. Distribution Deal With Cartessa

The agreement will bring VAIM's Juvelook Skincare Serum into U.S. dermatology clinics and medical spas.

Updated on Nov. 18, 2026 in Beauty

Flat opaque gouache-painted editorial illustration of an unlabeled amber dropper bottle beside a sculptural chrome device on a pale stone surface, evoking professional skincare in clinical settings.
Exclusive U.S. distribution rights for VAIM's Juvelook Skincare Serum, a post-treatment product used after laser and radio frequency microneedling, were signed by Cartessa Aesthetics of Melville, New York, on November 18, 2026. AI Illustration. Upload story photo >

VAIM has signed an exclusive distribution agreement with Cartessa Aesthetics, a medical aesthetic device distributor headquartered in Melville, New York. The agreement was announced on November 18, 2026, and Cartessa will handle sales and distribution of the Juvelook Skincare Serum within the United States.

Why it matters

The arrangement moves VAIM's professional cosmetic product beyond its existing online sales network and into medical institutions. For dermatology clinics and medical spas, it adds a post-treatment skincare option that is used following laser therapy or radio frequency microneedling.

The product was introduced to roughly 400 medical professionals and industry stakeholders at a Cartessa event in Miami last October. The announcement did not include sales figures, pricing, or distribution volume.

The players

VAIM

VAIM is a developer of professional cosmetics that is targeting the U.S. market with its Juvelook Skincare Serum.

Cartessa Aesthetics

Cartessa Aesthetics is a medical aesthetic device distributor headquartered in Melville, New York, that supplies laser and radio frequency microneedling devices to U.S. hospitals and medical spas.

The details

Under the agreement, Cartessa Aesthetics will handle sales and distribution of the Juvelook Skincare Serum in the U.S., while VAIM's U.S. subsidiary will provide product education and technical support. Cartessa supplies laser and radio frequency microneedling devices to hospitals and medical spas, and the serum has not yet been released domestically.

Timeline

  1. October 2026: VAIM introduced the product at a Cartessa event in Miami, Florida.

  2. November 18, 2026: VAIM announced the exclusive distribution agreement with Cartessa.

  3. November 2026: Supply of the serum to U.S. clinics and medical spas is set to begin.

Season Trajectory

The move follows a broader pattern in which cosmetics brands that began online are seeking professional clinic channels to reach consumers who receive in-office aesthetic treatments. It positions VAIM alongside other companies pursuing medical-aesthetic distribution in the U.S. market.

Clinics and medical spas that offer laser or radio frequency microneedling will be able to source the serum through Cartessa starting in November 2026. Consumers who receive these treatments may find the product recommended as part of post-procedure care rather than sold only online.

The takeaway

Professional skincare products are increasingly reaching consumers through the clinics that perform their treatments. Anyone planning a laser or microneedling procedure may want to ask their provider which post-treatment products they stock.

What happens next

Supply of the Juvelook Skincare Serum to U.S. dermatology clinics and medical spas is scheduled to begin in November 2026.

Further reading

For more on how skincare and treatment trends are shaping the category, explore Beauty.

Source note: This article includes information reported by 조선일보.